Quris

Quris: An AI Innovator Revolutionizing Drug DevelopmentQuris is an artificial intelligence (AI) innovator disrupting the pharmaceutical industry. Quris’ Bio-AI Clinical Prediction Platform better predicts which drug candidates will safely work in humans, avoiding the enormous costs of clinical trial failures. A unique machine learning approach generates data for classification algorithms by testing drugs on miniaturized patient-on-chips, then uses this automatically labeled data to train machine learning models. The first proprietary drug developed through the company’s Bio-AI Clinical Prediction Platform is preparing to enter Phase 1 clinical trials in 2022. It is a treatment for Fragile X Syndrome, a cause of autism and cognitive impairment.